Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

16.65 -0.57 (-3.31%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,793,427
Open	17.22
Bid (Size)	16.45 (100)
Ask (Size)	16.83 (4,000)
Prev. Close	17.22
Today's Range	16.58 - 17.25
52wk Range	9.490 - 19.26
Shares Outstanding	1,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Generic Pharmaceuticals Stocks Q2 Results: Benchmarking Amneal (NASDAQ:AMRX)

August 30, 2026

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal (NASDAQ:AMRX) and its peers. The g...

Via StockStory

1 Stock Under $50 with Solid Fundamentals and 2 Facing Challenges

August 26, 2026

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...

Via StockStory

Performance

YTD	+31.5%	+31.5%
1 Month	-9.6%	-9.6%
3 Month	+2.5%	+2.5%
6 Month	+39.4%	+39.4%
1 Year	+70.1%	+70.1%

More News

STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm

August 19, 2026

From Kaskela Law

Via Business Wire

1 Russell 2000 Stock with Exciting Potential and 2 We Ignore

August 19, 2026

Via StockStory

Amneal Pharmaceuticals (NASDAQ:AMRX) Soars on Q2 Earnings Beat and Raised Guidance ↗

July 30, 2026

Via Chartmill

Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader

August 10, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

1 Healthcare Stock Worth Your Attention and 2 We Ignore

August 07, 2026

Via StockStory

5 Insightful Analyst Questions From Amneal’s Q2 Earnings Call

August 06, 2026

Via StockStory

AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

July 31, 2026

Via StockStory

Amneal (AMRX) Q2 2026 Earnings Call Transcript ↗

July 30, 2026

Via The Motley Fool

Amneal Pharmaceuticals Q2 Earnings Call Highlights ↗

July 30, 2026

Via MarketBeat

Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

July 30, 2026

Via StockStory

Amneal Reports Second Quarter 2026 Financial Results

July 30, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal (AMRX) Reports Q2: Everything You Need To Know Ahead Of Earnings

July 28, 2026

Via StockStory

Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1

July 27, 2026

Via StockStory

Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm

July 23, 2026

From Kaskela Law LLC

Via Business Wire

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

July 17, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Reasons AMRX is Risky and 1 Stock to Buy Instead

July 15, 2026

Via StockStory

Amneal to Report Second Quarter 2026 Results on July 30, 2026

July 09, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

July 06, 2026

Via StockStory

1 Mooning Stock Worth Your Attention and 2 We Question

June 29, 2026

Via StockStory

1 Small-Cap Stock for Long-Term Investors and 2 We Find Risky

June 17, 2026

Via StockStory

3 Russell 2000 Stocks with Open Questions

June 10, 2026

Via StockStory

Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase ↗

June 09, 2026

Via MarketBeat

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

June 05, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?

Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.

What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?

Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market

What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 16.65

When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?

The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 09/15/26 04:00 PM ET

What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 16.65K

How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?

Amneal Pharmaceuticals, Inc. - Class A Common Stock has 17K shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.